First human test for new prostate drug begins

NCT ID NCT07404735

Summary

This is a very early study to see how a new drug called CKD-846 moves through the body and how safe it is. It will involve 32 healthy male volunteers. The main goal is to measure the drug's levels in the blood and check for any side effects, not to treat a medical condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Severance Hospital

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.